News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
723,183 Results
Type
Article (44050)
Company Profile (308)
Press Release (678825)
Section
Business (212274)
Career Advice (2183)
Deals (37093)
Drug Delivery (114)
Drug Development (84180)
Employer Resources (177)
FDA (16690)
Job Trends (15570)
News (359798)
Policy (34403)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (6)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (6)
2025 BioForest Digital (5)
2025 Lone Star Bio Digital (6)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2624)
Accelerated approval (2)
Adcomms (26)
Allergies (85)
Alliances (52005)
ALS (87)
Alzheimer's disease (1378)
Antibody-drug conjugate (ADC) (126)
Approvals (16677)
Artificial intelligence (249)
Autoimmune disease (18)
Automation (14)
Bankruptcy (377)
Best Places to Work (11842)
BIOSECURE Act (20)
Biosimilars (112)
Biotechnology (193)
Bladder cancer (57)
Brain cancer (26)
Breast cancer (251)
Cancer (2030)
Cardiovascular disease (163)
Career advice (1816)
Career pathing (32)
CAR-T (147)
Cell therapy (407)
Cervical cancer (17)
Clinical research (68124)
Collaboration (798)
Compensation (458)
Complete response letters (27)
COVID-19 (2676)
CRISPR (40)
C-suite (210)
Cystic fibrosis (101)
Data (1917)
Decentralized trials (2)
Denatured (27)
Depression (41)
Diabetes (255)
Diagnostics (6443)
Digital health (17)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (113)
Drug pricing (116)
Drug shortages (31)
Duchenne muscular dystrophy (87)
Earnings (88259)
Editorial (35)
Employer branding (21)
Employer resources (152)
Events (115670)
Executive appointments (646)
FDA (17802)
Featured Employer (51)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (703)
Gene editing (103)
Generative AI (23)
Gene therapy (292)
GLP-1 (761)
Government (4572)
Grass and pollen (4)
Guidances (48)
Healthcare (19136)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (117)
Indications (27)
Infectious disease (2814)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (46)
Intellectual property (85)
Interviews (340)
IPO (16926)
IRA (48)
Job creations (4161)
Job search strategy (1555)
Kidney cancer (10)
Labor market (34)
Layoffs (489)
Leadership (20)
Legal (8517)
Liver cancer (71)
Lung cancer (298)
Lymphoma (132)
Machine learning (2)
Management (61)
Manufacturing (284)
MASH (63)
Medical device (13449)
Medtech (13454)
Mergers & acquisitions (20633)
Metabolic disorders (685)
Multiple sclerosis (72)
NASH (20)
Neurodegenerative disease (86)
Neuropsychiatric disorders (30)
Neuroscience (1872)
NextGen: Class of 2025 (6725)
Non-profit (4552)
Northern California (2400)
Now hiring (37)
Obesity (379)
Opinion (245)
Ovarian cancer (73)
Pain (86)
Pancreatic cancer (77)
Parkinson's disease (137)
Partnered (18)
Patents (210)
Patient recruitment (94)
Peanut (50)
People (59551)
Pharmaceutical (98)
Pharmacy benefit managers (21)
Phase I (21226)
Phase II (29931)
Phase III (22420)
Pipeline (986)
Podcasts (86)
Policy (125)
Postmarket research (2685)
Preclinical (8932)
Press Release (68)
Prostate cancer (93)
Psychedelics (31)
Radiopharmaceuticals (252)
Rare diseases (376)
Real estate (6360)
Recruiting (67)
Regulatory (23319)
Reports (46)
Research institute (2389)
Resumes & cover letters (370)
Rett syndrome (3)
RNA editing (2)
RSV (43)
Schizophrenia (70)
Series A (123)
Series B (80)
Service/supplier (13)
Sickle cell disease (52)
Southern California (2073)
Special edition (17)
Spinal muscular atrophy (153)
Sponsored (29)
Startups (3789)
State (2)
Stomach cancer (14)
Supply chain (64)
The Weekly (56)
United States (21208)
Vaccines (687)
Venture capitalists (37)
Webinars (12)
Weight loss (276)
Women's health (34)
Worklife (16)
Date
Today (26)
Last 7 days (574)
Last 30 days (2665)
Last 365 days (34401)
2025 (7876)
2024 (36148)
2023 (40930)
2022 (52113)
2021 (56674)
2020 (55108)
2019 (47821)
2018 (36139)
2017 (33570)
2016 (33169)
2015 (39008)
2014 (32960)
2013 (28077)
2012 (30165)
2011 (30871)
2010 (28889)
Location
Africa (808)
Alabama (49)
Alaska (7)
Arizona (232)
Arkansas (14)
Asia (41548)
Australia (6602)
California (5492)
Canada (1871)
China (487)
Colorado (247)
Connecticut (258)
Delaware (128)
Europe (88991)
Florida (823)
Georgia (190)
Idaho (57)
Illinois (505)
India (24)
Indiana (303)
Iowa (9)
Japan (142)
Kansas (100)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (843)
Massachusetts (4168)
Michigan (210)
Minnesota (370)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (57)
New Hampshire (62)
New Jersey (1576)
New Mexico (31)
New York (1572)
North Carolina (960)
North Dakota (7)
Northern California (2400)
Ohio (193)
Oklahoma (14)
Oregon (39)
Pennsylvania (1247)
Puerto Rico (10)
Rhode Island (26)
South America (1182)
South Carolina (18)
South Dakota (1)
Southern California (2073)
Tennessee (93)
Texas (824)
Utah (167)
Virginia (136)
Washington D.C. (58)
Washington State (515)
West Virginia (3)
Wisconsin (50)
723,183 Results for "recludix pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Recludix Pharma to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 10, 2025
·
1 min read
Press Releases
Recludix Pharma to Present at the Annual J.P. Morgan Healthcare Conference
January 10, 2025
·
1 min read
Press Releases
Recludix Pharma to Participate in Two Investor Conferences in December
November 25, 2024
·
1 min read
Biotech Beach
Recludix Pharma to Participate in Two Investor Conferences in March 2024
Recludix Pharma, a leader in platform approaches to discover inhibitors of challenging targets for inflammatory disease and cancer, announced that members of Recludix’s management will host meetings at two investor conferences in March.
February 28, 2024
·
1 min read
Biotech Beach
Recludix Pharma to Present at Two Investor Conferences in February
Recludix Pharma, a leader in platform approaches to discover inhibitors of challenging targets for inflammatory disease and cancer, today announced that Nancy Whiting, Pharm.D., chief executive officer of Recludix, will present at two investor conferences in February.
February 6, 2024
·
1 min read
Biotech Beach
Recludix Pharma to Present at Two Investor Conferences in November 2023
Recludix Pharma announced that Nancy Whiting, Pharm.D., chief executive officer of Recludix, will present at two investor conferences in November.
November 9, 2023
·
1 min read
Business
Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immunology Expert, as Executive VP and Head of Research & Development, and Strengthens Scientific Advisory Board with the Addition of Dr. Adrian Ray
Recludix Pharma, a leader in platform approaches to discover inhibitors of challenging targets for inflammatory disease and cancer, announced the appointment of Ajay Nirula, M.D., Ph.D., as the company’s executive vice president and head of research and development, and the addition of Adrian S. Ray, Ph.D., to its scientific advisory board.
April 23, 2024
·
5 min read
Biotech Beach
Recludix Pharma Presents Data Demonstrating Oral STAT3 Inhibitors Drive Differentiated Efficacy and Safety in Preclinical Models of Th17 Mediated Skin Inflammation in Oral Plenary Session at SID Annual Meeting
Recludix Pharma presented new data today in an oral plenary presentation at the Society for Investigative Dermatology (SID) Annual Meeting titled “Oral selective STAT3 inhibitors demonstrate differentiated efficacy and safety potential in preclinical models of Th17 mediated skin inflammation” (abstract #738).
May 17, 2024
·
4 min read
Press Releases
Recludix Pharma to Present Data Demonstrating its Oral STAT3 Inhibitor has Differentiated Efficacy and Safety as Compared to JAK/TYK2 Inhibition in In Vivo Models of Inflammatory Arthritis
November 14, 2024
·
4 min read
Press Releases
Fierce Biotech Names Recludix Pharma a “Fierce 15” Biotech Company of 2024
August 5, 2024
·
4 min read
1 of 72,319
Next
